In support of concerns raised in the GPP guidelines relating to publication bias, Advances in Therapy aims to publish results from all well-designed and balanced studies, whether they report positive, negative, confirmatory or inconclusive data; and whether they relate to an international and/or a country-specific audience. We do not consider lack of interest or novelty to be in itself a reason for rejection.
Advances in Therapy offers Open Choice for all submitted articles, for maximum global visibility of your work. Open access guarantees your research is downloadable by an international audience of academics, physicians, healthcare providers, specialists, and the public worldwide.
Personal, commercial, academic, and financial interests from all contributors must be cited in the Acknowledgments section of the manuscript, to ensure transparency. If this is not declared at submission, our Technical Editing Team will liaise with the authors to make sure that all relevant relationships and competing interests are included in the published article.
Guidelines on data
Advances in Therapy will publish data that has been preregistered on clinical trial websites. However, if a trial registration number is available, it should be included at the end of the abstract.
Presentation at scientific meetings (in the form of abstracts or posters) is not considered to constitute full publication. We ask that the manuscript makes reference to such presentation of the data, and is included in the Acknowledgments section at the end of the manuscript.
All articles undergo a strict, double-blind peer review, conducted by at least two independent experts in the field. Articles are evaluated for medical and scientific accuracy, clinical relevancy, and to ensure the paper is balanced, objective, and methodologically sound. Advances in Therapy aims to publish results from all well-designed and balanced studies, whether they report positive, negative, confirmatory or inconclusive data. We do not consider lack of interest or novelty to be in itself a reason for rejection.
Adis Rapid+ have a strict policy against plagiarism. We use anti-plagiarism software to check all submissions before peer review. Any sections of text/figures/tables taken from another’s work must be used with the permission of the originator, and referenced appropriately, with text placed within quote marks. Authors submitting to Adis Rapid+ journals must sign a disclosure form, declaring that the submitted work is entirely their own, and is not under consideration for publication elsewhere.
If you wish to use figures/tables that have been previously published elsewhere, you must obtain permission from the original copyright holder. Please provide proof of permission when submitting your manuscript. Alternatively, proof of copyright can be e-mailed to email@example.com.